VTE for personal history of VTE +
inherited thrombiphilia
high dose LMWH once preg test is pos. till 6 weeks PP
or
until back on PO anticoagulant therapy
include haematology expert opinion
use high dose prophylaxis 50-75% of therpeutic dose
anti Xa monitoring
+/- antithrombin replacement during labour or CS
high prophylactic dose for women 50-90kg is 40mg BD of enoxaparin
5000 units of dalteparin BD
4500IU BD of tinzaparin
VTE for personal history of VTE + anitiphospholid syndrome
high dose LMWH once preg test is pos. till 6 weeks PP
or
until back on PO anticoagulant therapy
include haematology expert opinion
use high dose prophylaxis 50-75% of therpeutic dose
anti Xa monitoring
+/- antithrombin replacement during labour or CS
high prophylactic dose for women 50-90kg is 40mg BD of enoxaparin
5000 units of dalteparin BD
4500IU BD of tinzaparin
THIS IS VERY HIGH RISK
VTE if patient is on long term anticoagulant due to medical condition
stop warfarin once preg test pos , ideally before 6 w of preg
switch to high dose LMWH till delivery then switch back to warfarin
haematology expert option include
high prophylactic dose for women 50-90kg is 40mg BD of enoxaparin
5000 units of dalteparin BD
4500IU BD of tinzaparin
VTE FOR
previous VTE (unprovoked) in preg or estrogen related
NO inherited disorders
LMWH prophylactic dose from start of ANC til 6 weeks PP
THIS IS HIGH RISK- use standard dose
previous provide VTE ex. related to surgery
no risk of inherited thrombophilia
LMWH trophy dose from 28w till 6 weeks PP
THIS IS INTERMEDIATE RISK
Asymptomatic high-risk thrombophilia
what are they and how to manage VTE
-protein C or S deficiency
-those with more than one thrombophilia defect (including
*homozygous factor V Leiden,
*homozygous prothrombin gene mutation
*compound heterozygotes)
no personal hx of VTE
CONSIDER prophylaxis from 28 w , refer to local expert
recommend 6w PN LMWH
THIS IS INTERMEDIATE RISK
asymptomatic low risk thrbopholioa
what are they and how to manage
-heterozygotes for factor V Leiden
-heterozygone for prothrombin gene mutation
antiphospholipid antibodies
considered as 1 risk factor for thrombosis in asymptomatic women- calculate risk and give LMWH according to score
PN calculate risk and give according but 6 WEEKS IF SIGNIFICANT FAMILY HX OF VTE
THIS IS LOW RISK
points
prev VTE (not provoked)
4
points
prev VTE provoked by major surgery
3
points
known high risk thrombophilia
3
points
medica comorbidites which ones and how many points
3
cancer , heart failure,
active SLE, inflammatory pilyarthsropathy or inflammatory bower disease
nephrotic syndrome
Type 1 DM with nephropathy
sickle cell disease
current IVDU
points
fam history of unprovoked or estrogen related VTE in 1st deg relative
1
points
known low risk low risk thrombophilia (no VTE)
1
asymptomatic
-heterozygotes for factor V Leiden
-heterozygone for prothrombin gene mutation
antiphospholipid antibodies
points
age >35
1
points
obesity
1 or 2b
1 if BMI >/=30
2 if BMI > / = 40
points
parity > or = 3
1
smoker
1
gross varicose veins
1
PET in current preg
1
ART/IVF - antenatal only
1
multiple preg
1
CS in labour
2
elective CS
1
mid cavity or rational operative del
1